The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Pfizer-BionTech COVID-19 vaccine for emergency use in Nigeria.
NAFDAC Director-General, Prof Mojisola Adeyeye, made the announcement in Lagos on Friday at the agency headquarters.
Adeyeye said that the vaccine was approved partially so the agency can gather enough data within the period of the immunisation.
The NAFDAC boss said, “The purpose of the press briefing is to announce that NAFDAC has just approved Pfizer-BionTech vaccines for possible use in Nigeria.
“They were reviewed carefully by the NAFDAC staff COVID-19 vaccine committee to make sure that the science behind the development is well understood and in accord with our world regulatory activities.
“We used different mechanisms to approve the vaccine. We used reliance, meaning that a more mature regulatory agency across the globe, we can use that as a basis for our review.
“We will get the assessment report, know the peculiarity there, then our COVID-19 committee will get to do their job.”
Recall that the regulatory body had in February approved the AstraZeneca vaccine for use in Nigeria.